Phase 1, Open-Label, Randomized, Study of the Safety and Pharmacokinetics of HU6
Clinical trial NCT07170189 · COMPLETED
Trial details
- NCT number
- NCT07170189
- Sponsor
- Rivus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-13
- Primary completion
- 2025-12-04
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.